ASAM publishes 5th edition of Principles of Addiction Medicine

ASAM Publishes 5th Edition of Principles of Addiction Medicine

The American Society of Addiction Medicine has published the 5th edition of its textbook, Principles of Addiction Medicine (PADM-5). At more than 1,700 pages, the book is a comprehensive reference designed for all physicians and other health professionals who care for patients with substance use disorders.

PADM-5 addresses the scientific principles underlying addiction and its management, as well as the practical steps involved in patient care. Chapters by leading researchers and other addiction experts cover core issues such as the basic science of addiction medicine; the pharmacology of drugs of abuse; the steps involved in diagnosis, assessment and early intervention; medication-assisted treatment and behavioral therapies; integrating mutual help and Twelve Step programs into the overall treatment plan; management of co-occurring addiction, medical and psychiatric disorders; and the ethical, legal and liability issues involved in addiction care.

In addition, the 5th edition features entirely new chapters on prescription drug abuse; club drugs; the nurse’s role in addressing addiction; conceptual and treatment issues raised by behavioral addictions; rehabilitation approaches to comorbid pain and addiction; management of adolescents with substance use disorders; and the prevention and treatment of substance use disorders in military personnel and veterans.

Another new feature of the 5th edition is an interactive eBook version, which offers tablet, smartphone, or online access to:

  • The complete contents of the print edition, with enhanced navigation
  • Appendices that do not appear in the print edition
  • Cross-linked pages and references for easy navigation
  • A powerful search feature that pulls results from the entire book and even the web
  • The ability to highlight text to simplify future searches for key content
  • The ability to share notes with friends and colleagues
  • The ability to save preferred content for quick reference in the future
  • An interactive question bank with more than 300 questions.

PADM-5 is available from major online booksellers or directly from the publisher, Wolters Kluwer Health (http://www.lww.com/Cart?id=9781451173574&quantity=1&promoCode=WEA020AG).

Wolters Kluwer Health (ISBN: 978-1-4511-7357-4).

Hardbound, 1,795 pages. Published June 2014.

Senior Editor

Richard K. Ries. M.D., FAPA, FASAM, Professor of Psychiatry at the University of Washington Medical School, Seattle, and Associate Director of the University of Washington Addiction Psychiatry Residency Program

Associate Editors

David A. Fiellin, M.D., Professor of Medicine, Investigative Medicine and Public Health, Yale University School of Medicine, New Haven, Connecticut

Shannon C. Miller M.D., FASAM, DFAPA, Program Director, VA Fellowship in Addiction Medicine Research, Cincinnati VAMC; Co-Program Director, Addiction Psychiatry Fellowship and Associate Director of Education & Training, University of Cincinnati School of Medicine

Richard Saitz M.D., M.P.H., FACP, FASAM, Professor of Medicine and Epidemiology and Director of the Clinical Addiction Research and Education (CARE) Unit in the Section of General Internal Medicine, Boston University

Schools of Medicine and Public Health and Boston Medical Center.


PCSS-MAT Announces Additions to Webinar Archive 

The Provider Clinical Support System for Medication-Assisted Treatment (PCSS-MAT) recently announced the addition of the following webinars to its web archive, where they can be accessed at no charge. CME credit is available for most webinars.

The webinars listed below were sponsored by the American Psychiatric Association except where otherwise noted.

A Review of and Perspectives on Buprenorphine Diversion and Misuse: Implications for Policy and Practice. Faculty: Michelle Lofwall, M.D. (webinar date: September 9, 2014).

Addressing Opioid Misuse and Abuse: ONDCP and SAMHSA Partnership to Reduce Risk of Overdose. Faculty: Michael Botticelli and Elinore F. McCance-Katz, M.D., Ph.D. (webinar date: September 30, 2014).

Biology and Behavior: Neuroadaptations to Opioids and Their Consequences for Addiction. Faculty: Kevin A. Sevarino, M.D., Ph.D. (webinar date October 9, 2014). Sponsored by the American Academy of Addiction Psychiatry.

Clinical Case Reviews: Managing Diversion and Misuse in Office-Based Opioid Treatment. Faculty: Michelle Lofwall, M.D. (webinar date: September 24, 2014).

Implementing Antagonist-Based Relapse Prevention Treatment in your Practice. Faculty: Adam Bisaga, M.D. (webinar date: July 31, 2014)

Managing Acute and Chronic Pain in Patients on Medication-Assisted Treatment. Faculty: Daniel P. Alford, M.D., M.P.H. and John A. Renner, Jr., M.D. (webinar date: August 12, 2014). 

Managing Diversion and Misuse in Office-Based Opioid Treatment (OBOT) – Clinical Case Review (webinar date: September 24, 2014).

Managing Pain in Older Persons: A Focus on Opioid Safety. Faculty: Carol P. Curtiss, M.S.N., R.N.-BC (webinar date: August 22, 2014). Sponsored by the American Society of Pain Management Nurses.

Methadone and Buprenorphine: Clinical Impact of Drug Interactions. Faculty: Elinore F. McCance-Katz, M.D., Ph.D. (webinar date: March 11, 2014)

Motivational Interviewing. Faculty: Petros Levounis, M.D., M.A. (webinar date: July 8, 2014). Sponsored by the American Academy of Addiction Psychiatry.

Naltrexone (Extended-Release Naltrexone [XR-NTX]) Primer. Faculty: Joshua D. Lee, M.D., M.Sc. (webinar date: May 8, 2014). Sponsored by the American Academy of Addiction Psychiatry.

Neonatal Abstinence Syndrome – A Clinical Primer. Faculty: Lori Devlin, D.O., M.H.A. (webinar date: April 22, 2014)

Prescription Drug Abuse and the Emergence of Hepatitis C in Rural Appalachia. Faculty: Jennifer R. Havens, Ph.D., M.P.H. (webinar date: July 29, 2014).

The Psychology of AA and NA and Their Role in Clinical Care. Faculty: Marc Galanter, M.D. (webinar date: April 8, 2014).

Update from the Drug Enforcement Administration. Faculty: Cathy Gallagher (webinar date: October 14, 2014).

The PCSS-MAT is a collaboration of the American Academy of Addiction Psychiatry (lead), the American Psychiatric Association, the American Osteopathic Academy of Addiction Medicine, the American Society of Addiction Medicine and a number of other organizations, including COPE. Funding support for the PCSS-MAT is provided by the Substance Abuse and Mental Health Services Administration (SAMHSA).

For a complete schedule of upcoming webinars, a list of all archived webinars, and to explore the mentoring program and other resources offered through the PCSS-MAT, visit http://www.pcssmat.org.

AMA Provides Guidance to Physicians on Ensuring Patient Access to Needed Opioid Analgesics

The American Medical Association (AMA) has published a fact sheet designed to help physicians comply with new federal regulations on prescribing hydrocodone while avoiding disruptions in patient care.

The rule, issued by the U.S. Drug Enforcement Administration (DEA) with an effective date of October 6, 2014, reschedules hydrocodone combination products (HCPs) into Controlled Substance Schedule II. The AMA says that millions of patients will be affected by the new rule, and that the fact sheet is intended to help physicians avoid interruptions in access to medically necessary medications for their patients.

In releasing the fact sheet, AMA President Robert M. Wah, M.D., said, “The AMA is strongly committed to combatting prescription drug abuse and diversion while at the same time preserving patient access to medically necessary treatments for pain. This new fact sheet explains how new regulatory changes impact both physicians and pharmacists, which will help ensure patients continue having access to the care they need under the new federal rule.”

The fact sheet advises that prescriptions for HCPs issued before October 6th that have authorized refills can be dispensed in accordance with current DEA rules until April 8, 2015. However, because of limitations that may be imposed by state laws or insurers, the AMA is encouraging prescribers to act now to provide new hard copy or electronic prescriptions for patients rather than depending on existing refills.

Source: American Medical Association, September 18,. 2014 (accessed at http://www.ama-assn.org/ama/pub/news/news/2014/2014-09-18-new-dea-rule-fact-sheet.page?).